Text Size

Risk Factors for Shoulder Pain and Emesis After Laparoscopic Cholecystectomy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Taipei Veterans General Hospital,Taiwan.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Taipei Veterans General Hospital,Taiwan
ClinicalTrials.gov Identifier:
NCT01095536
First received: March 28, 2010
Last updated: October 4, 2010
Last verified: March 2010
History of Changes
  Purpose

Risk factors for postoperative shoulder pain after laparoscopic cholecystectomy were not clear. Moreover, risk factors for postoperative emesis specially for this surgery were not detailed and accurate. The present study is a prospective cohort study to identify risk factors for shoulder pain and emesis within 24 hours in Chinese patients after laparoscopic cholecystectomy under general anesthesia.


Condition
Shoulder Pain
Nausea
Vomiting

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Observational Cohort Study to Identify Risk Factors for Shoulder Pain and Emesis After Laparoscopic Cholecystectomy Under General Anesthesia

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Taipei Veterans General Hospital,Taiwan:

Primary Outcome Measures:
  • incidence of postoperative shoulder pain and emesis [ Time Frame: within postoperative 24 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 380
Study Start Date: February 2010
Estimated Study Completion Date: February 2011
Estimated Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Detailed Description:

The present study is a prospective cohort study to identify risk factors for shoulder pain and emesis within 24 hours in Chinese patients after laparoscopic cholecystectomy under general anesthesia.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients scheduled for elective laparoscopic cholecystectomy

Criteria

Inclusion Criteria:

  • > 21 years old,
  • Chinese patient

Exclusion Criteria:

  • current pregnancy,
  • patients with history of upper laparotomy,
  • inability to communicate before operation,
  • persistent emesis or shoulder pain before operation,
  • patients who converted to open cholecystectomy,
  • receiving postoperative ventilator support,
  • unstable postoperative condition or major complications.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01095536

Locations
Taiwan
Department of Anesthesiology, Taipei Veterans General Hospital Recruiting
Taipei, Taiwan, 112
Contact: Chiu-Ming Ho, M.D., Ph.D     886-2-28757549 ext 350     cmho@vghtpe.gov.tw    
Sponsors and Collaborators
Taipei Veterans General Hospital,Taiwan
Investigators
Principal Investigator: Chiu-Ming Ho, M.D., Ph.D. Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan
  More Information

No publications provided

Responsible Party: Chiu-Ming Ho, M.D., Ph.D./Associate Professor and Attending Anesthesiologist, Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan
ClinicalTrials.gov Identifier: NCT01095536     History of Changes
Other Study ID Numbers: 201001019IC
Study First Received: March 28, 2010
Last Updated: October 4, 2010
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Taipei Veterans General Hospital,Taiwan:
laparoscopic cholecystectomy, elective
anesthesia, general
shoulder pain
nausea
 vomiting
laparoscopic cholecystectomy
general anesthesia

Additional relevant MeSH terms:
Nausea
Shoulder Pain
Vomiting
Signs and Symptoms, Digestive
Signs and Symptoms
Arthralgia
Joint Diseases
Musculoskeletal Diseases
 Pain
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 16, 2013